Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry K Keefer

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Molecular Cancer Therapeutics|June 24, 2004
Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulationJie Liu, Chengxiu Li, Wei Qu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogensJessica M Faupel-Badger, Barbara J Fuhrman, Xia Xu, et al.
Journal of Materials Chemistry|December 7, 2010
Tailored Synthesis of Nitric Oxide-Releasing Polyurethanes Using O-Protected Diazeniumdiolated Chain ExtendersMelissa M Reynolds, Joseph E Saavedra, Brett M Showalter, et al.
Macromolecular Bioscience|February 23, 2011
Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasiaM Concepcion Serrano, Ashley K Vavra, Michele Jen, et al.
Drug Design, Development and Therapy|August 8, 2009
Structure-Based Design of Anticancer Prodrug PABA/NOXinhua Ji, Ajai Pal, Ravi Kalathur, et al.
Cancer Research|December 7, 2011
Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal womenA Heather Eliassen, Donna Spiegelman, Xia Xu, et al.
Analytical Chemistry|October 15, 2005
Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometryXia Xu, Timothy D Veenstra, Stephen D Fox, et al.
Journal of Pharmaceutical Sciences|November 30, 2005
Injectable formulation of disodium 1-[2-(carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolate (PROLI/NO), an ultrafast nitric oxide donor prodrugDavid J Waterhouse, Joseph E Saavedra, Keith M Davies, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2010
The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen speciesAnna E Maciag, Harinath Chakrapani, Joseph E Saavedra, et al.
Nitric Oxide : Biology and Chemistry|September 7, 2014
Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolatesGaurav Bharadwaj, Patricia G Z Benini, Debashree Basudhar, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Molecular Cancer Therapeutics|June 24, 2004
Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulationJie Liu, Chengxiu Li, Wei Qu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 9, 2010
Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogensJessica M Faupel-Badger, Barbara J Fuhrman, Xia Xu, et al.
Journal of Materials Chemistry|December 7, 2010
Tailored Synthesis of Nitric Oxide-Releasing Polyurethanes Using O-Protected Diazeniumdiolated Chain ExtendersMelissa M Reynolds, Joseph E Saavedra, Brett M Showalter, et al.
Macromolecular Bioscience|February 23, 2011
Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasiaM Concepcion Serrano, Ashley K Vavra, Michele Jen, et al.
Drug Design, Development and Therapy|August 8, 2009
Structure-Based Design of Anticancer Prodrug PABA/NOXinhua Ji, Ajai Pal, Ravi Kalathur, et al.
Cancer Research|December 7, 2011
Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal womenA Heather Eliassen, Donna Spiegelman, Xia Xu, et al.
Analytical Chemistry|October 15, 2005
Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometryXia Xu, Timothy D Veenstra, Stephen D Fox, et al.
Journal of Pharmaceutical Sciences|November 30, 2005
Injectable formulation of disodium 1-[2-(carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolate (PROLI/NO), an ultrafast nitric oxide donor prodrugDavid J Waterhouse, Joseph E Saavedra, Keith M Davies, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2010
The nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen speciesAnna E Maciag, Harinath Chakrapani, Joseph E Saavedra, et al.
Nitric Oxide : Biology and Chemistry|September 7, 2014
Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolatesGaurav Bharadwaj, Patricia G Z Benini, Debashree Basudhar, et al.
Pageof 12